Mostrar el registro sencillo del ítem

Integrated treatment to achieve functional recovery for first-episode psychosis

dc.creatorValencia, Marcelo
dc.creatorJuarez, Francisco
dc.creatorOrtega, Hector
dc.date.accessioned2017-06-29T03:54:08Z
dc.date.available2017-06-29T03:54:08Z
dc.date.issued2012es_ES
dc.identifier2770es_ES
dc.identifier.issn2090-2085es_ES
dc.identifier.urihttps://doi.org/10.1155/2012/962371es_ES
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/4619
dc.description.abstractes_ES
dc.language.isoenges_ES
dc.publisherCairo : Hindawi Pub. Corpes_ES
dc.relation2012, 1-10 p.es_ES
dc.relationversión del editores_ES
dc.rightsacceso cerradoes_ES
dc.subject.meshes_ES
dc.titleIntegrated treatment to achieve functional recovery for first-episode psychosises_ES
dc.title.alternativees_ES
dc.typeartículoes_ES
dc.contributor.affiliationDivision of Epidemiological and Psychosocial Research, National Institute of Psychiatry “Ram´on de la Fuente”,Calzada Mexico-Xochimilco 101, Colonia San Lorenzo Huipulco, 14370 Mexico City, Mexicoes_ES
dc.contributor.emailvalencm@imp.edu.mxes_ES
dc.relation.jnabreviadoSCHIZOPHR RES TREATMENTes_ES
dc.relation.journalSchizophrenia Research and Treatmentes_ES
dc.identifier.placeEgiptoes_ES
dc.date.published2012es_ES
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñizes_ES
dc.identifier.eissn2090-2093es_ES
dc.identifier.doi10.1155/2012/962371es_ES
dc.description.monthes_ES
dc.description.abstractotrodiomaThis study describes an integrated treatment approach that was implemented to enhance functional recovery in first-episode psychotic patients. Patients were randomized to two treatment conditions: either to an integrated treatment approach: pharmacotherapy, psychosocial treatment, and psychoeducation (experimental group: 푁 = 3 9 ) or to medication alone (control group: 푁 = 3 4 ). Patients were evaluated at baseline and after one year of treatment. Functional recovery was assessed according to symptomatic and functional remission. At the end of treatment, experimental patients showed a 94.9% of symptomatic remission compared to 58.8% of the control group. Functional remission was 56.4% for the experimental group and 3.6% for the control group, while 56.4% of the experimental group met both symptomatic and functional remission criteria and were considered recovered compared to 2.9% of the control group.es_ES
dc.subject.meshmes_ES
dc.subject.kwes_ES
dc.subject.koes_ES


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem